Davis Polk advised the underwriters in connection with the $90 million initial public offering of common stock by Kodiak Sciences Inc. The common stock is listed on the NASDAQ Global Market under the symbol “KOD.”
Kodiak Sciences is a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases. Kodiak Sciences is based in Palo Alto, California.
The Davis Polk corporate team included partner Bruce K. Dallas and associates Emily Roberts and Billie Solomon. Associate Jason J. Bang provided intellectual property and technology advice. The tax team included partner Rachel D. Kleinberg and associate M. Brett Cameron. Counsel Marcie A. Goldstein provided FINRA advice. Associate Sijia Cai provided 1940 Act advice. Counsel Ron M. Aizen and associate Timothy John Durbin provided executive compensation advice. Members of the Davis Polk team are based in the Northern California and New York offices.